COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,363 Articles (22,803 medRxiv, 8,560 bioRxiv)

Most recent first Previous |  Page 1350: Articles 13491-13500  | Next

Tracking Cryptic SARS-CoV-2 Lineages Detected in NYC Wastewater
Smyth, D. S., Trujillo, M., Gregory, D. A., Cheung, K., Gao, A., Graham, M., Guan, Y., Guldenpfennig, C., Hoxie, I., Kannoly, S., Kubota, N., Lyddon, T. D., Markman, M., Rushford, C., San, K. M., Sompanya, G., Spagnolo, F., Suarez, R., Teixeiro, E., Daniels, M., Johnson, M., Dennehy, J. J.
10.1101/2021.07.26.21261142 — Posted: 2021-07-29
Reactive vaccination of workplaces and schools against COVID-19
Faucher, B., Assab, R., Roux, J., Levy-Bruhl, D., Tran Kiem, C., Cauchemez, S., Zanetti, L., Colizza, V., Boëlle, P.-Y., Poletto, C.
10.1101/2021.07.26.21261133 — Posted: 2021-07-29
The human nose organoid respiratory virus model: an ex-vivo human challenge model to study RSV and SARS-CoV-2 pathogenesis and evaluate therapeutics
Rajan, A., Weaver, A. M., Alosio, G. M., Jelinski, J., Johnson, H. L., Venable, S. F., McBride, T., Aideyan, L., Piedra, F.-A., Ye, X., Melicoff-Portillo, E., Yerramilli, M. R. K., Zeng, X.-L., Mancini, M. A., Stossi, F., Maresso, A. W., Kotkar, S. A., Estes, M. K., Blutt, S., Avadhanula, V., Piedra, P. A.
10.1101/2021.07.28.453844 — Posted: 2021-07-28
BRET-based self-cleaving biosensors for SARS-CoV-2 3CLpro Inhibitor Discovery
Hou, N., Peng, C., Zhang, L., Zhu, Y., Hu, Q.
10.1101/2021.07.28.454072 — Posted: 2021-07-28
SARS-CoV-2 Lambda variant exhibits higher infectivity and immune resistance
Kimura, I., Kosugi, Y., Wu, J., Yamasoba, D., Butlertanaka, E. P., Tanaka, Y. L., Liu, Y., Shirakawa, K., Kazuma, Y., Nomura, R., Horisawa, Y., Tokunaga, K., Takaori-Kondo, A., Arase, H., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Saito, A., Nakagawa, S., Sato, K.
10.1101/2021.07.28.454085 — Posted: 2021-07-28 Discussion: Onsite
The Achilles' heel of coronaviruses: targeting the 5' Polyuridines tract of the antigenome to inhibit Mouse coronavirus virus-induced cell death
Ullah, H., Averick, S., Tang, Q.
10.1101/2021.07.26.453908 — Posted: 2021-07-28
SARS-CoV-2 in the Republic of Guinea: Fragment and Whole-Genome Sequencing, Phylogenetic Analysis
Kritsky, A. A., Krasnov, Y. M., Keita, M., Keita, S., Fedorov, A. V., Shevtsova, A. P., Guseva, N. P., Kazorina, E. V., Sosedova, E. A., Katyshev, A. D., Naryshkina, E. A., Kolomoets, E. V., Shcherbakova, S. A., Popova, A. Y., Kutyrev, V. V.
10.1101/2021.07.28.454098 — Posted: 2021-07-28
Single-Cell Profiling of the Antigen-Specific Response to BNT162b2 SARS-CoV-2 RNA Vaccine
Kramer, K. J., Wilfong, E. M., Voss, K., Barone, S., Shiakolas, A. R., Raju, N., Roe, C. E., Suryadevara, N., Walker, L. M., Wall, S. C., Paulo, A., Schaefer, S., Dahunsi, D., Westlake, C. S., Crowe, J. E., Carnahan, R. H., Rathmell, J. C., Bonami, R. H., Georgiev, I. S., Irish, J. M.
10.1101/2021.07.28.453981 — Posted: 2021-07-28
Monitoring and forecasting the SARS-Covid-19 pandemic in France
Reingruber, J., Papale, A., Ruckly, S., Timsit, J.-F., Holcman, D.
10.1101/2021.07.28.21260870 — Posted: 2021-07-28
Higher serological responses and increased vaccine effectiveness demonstrate the value of extended vaccine schedules in combatting COVID-19 in England
Amirthalingam, G., Lopez Bernal, J., Andrews, N. J., Whitaker, H., Gower, C., Stowe, J., Tessier, E., Subbarao, S., Ireland, G., Baawuah, F., Linley, E., Warrener, L., O'Brien, M., Whillock, C., Moss, P., Ladhani, S. N., Brown, K. E., Ramsay, M. E.
10.1101/2021.07.26.21261140 — Posted: 2021-07-28 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).